Reducing the Prescribing of Heavily Marketed Medications: A Randomized Controlled Trial
- 129 Downloads
Prescription drug costs are a major component of health care expenditures, yet resources to support evidence-based prescribing are not widely available.
To evaluate the effectiveness of computerized prescribing alerts, with or without physician-led group educational sessions, to reduce the prescribing of heavily marketed hypnotic medications.
Cluster-randomized controlled trial.
We randomly allocated 14 internal medicine practice sites to receive usual care, computerized prescribing alerts alone, or alerts plus group educational sessions.
Proportion of heavily marketed hypnotics prescribed before and after the implementation of computerized alerts and educational sessions.
The activation of computerized alerts held the prescribing of heavily marketed hypnotic medications at pre-intervention levels in both the alert-only group (adjusted risk ratio [RR] 0.97; 95% CI 0.82–1.14) and the alert-plus-education group (RR 0.98; 95% CI 0.83–1.17) while the usual-care group experienced an increase in prescribing (RR 1.31; 95% CI 1.08–1.60). Compared to the usual-care group, the relative risk of prescribing heavily marketed medications was less in both the alert-group (Ratio of risk ratios [RRR] 0.74; 95% CI 0.57–0.96) and the alert-plus-education group (RRR 0.74; 95% CI 0.58–0.97). The prescribing of heavily marketed medications was similar in the alert-group and alert-plus-education group (RRR 1.02; 95% CI 0.80–1.29). Most clinicians reported that the alerts provided useful prescribing information (88%) and did not interfere with daily workflow (70%).
Computerized decision support is an effective tool to reduce the prescribing of heavily marketed hypnotic medications in ambulatory care settings.
clinicaltrials.gov Identifier: NCT00788346.
KEY WORDSprescription drugs effectiveness marketed medications prescribing decision support computerized alerts
This work was supported by a grant from the State Attorney General Consumer and Prescriber Education Grant Program, which is funded through the multi-state settlement from the unlawful marketing of the prescription drug Neurontin®. Dr. Fortuna was supported by an Institutional National Research Service Award, #5 T32 HP11001–18.
Conflict of Interest
- 2.Center for Medicare & Medicaid Services. National Health Expenditure Accounts 2006 Highlights. http://www.cms.hhs.gov/NationalHealthExpendData/downloads/highlights.pdf. 2006. Accessed April 21, 2009.
- 3.US Government Accountability Office. Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising (GAO-07–54). 11–16–0008.Google Scholar
- 17.The Department of Justice. Warner-Lambert to Pay $430 Million to Resolve Criminal & Civil Health Care Liability Relating to Off-Label Promotion. The Department of Justice. http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm. Accessed April 21, 2009.
- 18.Oregon Health & Science University. Attorney General Consumer and Prescriber Grant Program. State Attorney Generals. http://www.ohsu.edu/cpgp. Accessed April 21, 2009.
- 19.Express Scripts. 2006 Drug Trend Report. http://www.express-scripts.com/industryresearch/industryreports/drugtrendreport/2006. Accessed April 21, 2009.
- 20.Atrius Health Pharmacy & Therapeutics Committee. Fact Sheet Hypnotics for Insomnia. 2–27–2008.Google Scholar
- 32.O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007;CD000409.Google Scholar
- 35.Peter Loftus. PHARMA MARKET: Glow Of Sepracor Sleep Drug Gets Dimmer. Dow Jones Newswires. http://www.istockanalyst.com/article/viewiStockNews/articleid/2342109. Accessed April 21, 2009.
- 36.Sanofi-Aventis. United States Securities and Exchange Commission Form 20-F. United States Securities and Exchange Commission, 83. http://en.sanofi-aventis.com/binaries/20-F_2007_EN_tcm28–1519.pdf. Accessed April 21, 2009.s
- 39.Simon SR, Soran CS, Kaushal R, Jenter CA, Volk LA, Burdick E, Cleary PD, Orav EJ, Poon EG, and Bates DW. Physicians’ Usage of Key Functions in Electronic Health Records from 2005 to 2007: A Statewide Survey. J Am Med Inform Assoc 2009; In press.Google Scholar